首页 | 本学科首页   官方微博 | 高级检索  
检索        

消化系统恶性肿瘤患者血清丙型肝炎病毒抗体(抗HCV)的感染情况
引用本文:陈士葆,沈健伟.消化系统恶性肿瘤患者血清丙型肝炎病毒抗体(抗HCV)的感染情况[J].中国肿瘤临床,1994,21(5):332-334.
作者姓名:陈士葆  沈健伟
作者单位:第二军医大学长征医院消化内科 上海市200003
摘    要:作者等应用抗HCV酶联免疫分析(EIA)试验药盒对93例消化系统恶性肿瘤疾病患者作血清抗HCV测定.血清抗HCV流行率在41例健康献血员为4.87%;在6例食管癌、15例进展期胃癌、13例结直肠癌、54例原发性肝癌及其它恶性肿瘤5例的检出率分别为0%、13.3%7.69%、9.25%和0%.除HCC组外,各组患者的抗HCV流行率和HB_sAg阳性与否无关.因此,对健康献血员及各种疾病患者在作肝功能及HBV系列测定同时应作抗HCV测定,对血清抗HCV阳性者应进行积极的治疗.

关 键 词:消化系统  恶性肿瘤  血清丙型肝炎病毒抗体(抗HCV)

The Prevalence of Hapatitis C Virus Antibodies in Patients with Digestive Tract Malignancies
Chen Shi-Bao et al.The Prevalence of Hapatitis C Virus Antibodies in Patients with Digestive Tract Malignancies[J].Chinese Journal of Clinical Oncology,1994,21(5):332-334.
Authors:Chen Shi-Bao
Institution:Chen Shi-Bao et al Department of Digestion,Chang-Zheng Hospital. Shanghai
Abstract:Serum anti-HCV was measured by enzyme immunoassay in 93 patients with various digestive tract malignancies (esophagus 6,stomach 15, colorectal 13,liver 54 and miscellaneous 5),and in 41 healthy blood donors as control.The overall prevalence of antibody to hepatitis C virus was 4. 87% among 41 unselected blood donors,and 0%, 13. 3% ,7. 6% ,9. 25%and 0% respectively in malignancies mentioned above.The results showed that there was no significant difference(P>0. 05)between studied patients and blood donors.It is emphasized that serum anti-HCV as well as the liver function tests and HBV markers should be examined in blood donors and that individuals positive with anti-HCV should be treated actively.
Keywords:Digestive system Malignant tumor Anti-HCV Antibody
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号